Gain Therapeutics, Inc. · NASDAQ:GANX

Gain Therapeutics, Inc. shareholders

As of Sep 30, 2026, 48 institutions reported holding Gain Therapeutics, Inc., 19.0% of its shares. Largest: Marshall Wace, LLP, Potomac Capital Management, Inc. and Jones Financial Companies Lllp. New holders, exits, insiders and big stakes, each with its filing.

HolderShares% of Gain Therapeutics, Inc.ChangeFiled
Marshall Wace, LLP1.68M3.8%−243KNov 13, 2026
Potomac Capital Management, Inc.930K2.1%−16,400Nov 13, 2026
Jones Financial Companies Lllp739K1.7%+131KNov 13, 2026
Vanguard730K1.6%no changeNov 13, 2026
Gsa Capital Partners LLP635K1.4%+2,585Nov 16, 2026
Cambridge Investment Research Advisors, Inc.567K1.3%−571KNov 2, 2026
DME Capital Management, LP566K1.3%no changeNov 16, 2026
Geode Capital470K1.1%+16,034Nov 6, 2026
BlackRock268K0.60%−6,636Nov 13, 2026
UBS241K0.54%+26,471Nov 10, 2026

Gain Therapeutics, Inc. insider trades